Review



f9 cells  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    ATCC f9 cells
    Effects of 24-h pre-incubation of <t>F9</t> cells with protein solvent buffer or various concentrations of recombinant SELENOV on cell viability. ( A ) Viability cytogram of F9 cells following treatment with 100 μL/mL (equivalent to 50 μg/mL SELENOV application) or 200 μL/mL (equivalent to 100 μg/mL SELENOV application) of solvent buffer. The 10 μg/mL SELENOV group was compared to the untreated control, as the corresponding buffer volume was negligible. ( B ) Viability cytogram of F9 cells after treatment with different concentrations of recombinant SELENOV. ( C ) Effects of solvent buffer or recombinant SELENOV on cell viability and activation of cell death pathways. Data are presented as mean ± SEM. Statistical significance was determined by one-way ANOVA followed by Tukey’s post hoc test. *** p < 0.001 versus the Control group; ### p < 0.001 versus the corresponding Buffer group.
    F9 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 2848 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/f9+cells/pmc12730894-90-7-29?v=ATCC
    Average 99 stars, based on 2848 article reviews
    f9 cells - by Bioz Stars, 2026-07
    99/100 stars

    Images

    1) Product Images from "Exogenous Selenoprotein V Induces Apoptosis in Murine Testicular Teratoma Cells via Mitochondrial Dysfunction and ROS Overproduction"

    Article Title: Exogenous Selenoprotein V Induces Apoptosis in Murine Testicular Teratoma Cells via Mitochondrial Dysfunction and ROS Overproduction

    Journal: Biomolecules

    doi: 10.3390/biom15121733

    Effects of 24-h pre-incubation of F9 cells with protein solvent buffer or various concentrations of recombinant SELENOV on cell viability. ( A ) Viability cytogram of F9 cells following treatment with 100 μL/mL (equivalent to 50 μg/mL SELENOV application) or 200 μL/mL (equivalent to 100 μg/mL SELENOV application) of solvent buffer. The 10 μg/mL SELENOV group was compared to the untreated control, as the corresponding buffer volume was negligible. ( B ) Viability cytogram of F9 cells after treatment with different concentrations of recombinant SELENOV. ( C ) Effects of solvent buffer or recombinant SELENOV on cell viability and activation of cell death pathways. Data are presented as mean ± SEM. Statistical significance was determined by one-way ANOVA followed by Tukey’s post hoc test. *** p < 0.001 versus the Control group; ### p < 0.001 versus the corresponding Buffer group.
    Figure Legend Snippet: Effects of 24-h pre-incubation of F9 cells with protein solvent buffer or various concentrations of recombinant SELENOV on cell viability. ( A ) Viability cytogram of F9 cells following treatment with 100 μL/mL (equivalent to 50 μg/mL SELENOV application) or 200 μL/mL (equivalent to 100 μg/mL SELENOV application) of solvent buffer. The 10 μg/mL SELENOV group was compared to the untreated control, as the corresponding buffer volume was negligible. ( B ) Viability cytogram of F9 cells after treatment with different concentrations of recombinant SELENOV. ( C ) Effects of solvent buffer or recombinant SELENOV on cell viability and activation of cell death pathways. Data are presented as mean ± SEM. Statistical significance was determined by one-way ANOVA followed by Tukey’s post hoc test. *** p < 0.001 versus the Control group; ### p < 0.001 versus the corresponding Buffer group.

    Techniques Used: Incubation, Solvent, Recombinant, Control, Activation Assay



    Similar Products

    f9 cells  (ATCC)
    99
    ATCC f9 cells
    Effects of 24-h pre-incubation of <t>F9</t> cells with protein solvent buffer or various concentrations of recombinant SELENOV on cell viability. ( A ) Viability cytogram of F9 cells following treatment with 100 μL/mL (equivalent to 50 μg/mL SELENOV application) or 200 μL/mL (equivalent to 100 μg/mL SELENOV application) of solvent buffer. The 10 μg/mL SELENOV group was compared to the untreated control, as the corresponding buffer volume was negligible. ( B ) Viability cytogram of F9 cells after treatment with different concentrations of recombinant SELENOV. ( C ) Effects of solvent buffer or recombinant SELENOV on cell viability and activation of cell death pathways. Data are presented as mean ± SEM. Statistical significance was determined by one-way ANOVA followed by Tukey’s post hoc test. *** p < 0.001 versus the Control group; ### p < 0.001 versus the corresponding Buffer group.
    F9 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/f9+cells/pmc12730894-90-7-29?v=ATCC
    Average 99 stars, based on 1 article reviews
    f9 cells - by Bioz Stars, 2026-07
    99/100 stars
    		  Buy from Supplier
    mouse f9 embryo carcinoma cells  (ATCC)
    95
    ATCC mouse f9 embryo carcinoma cells
    Effects of 24-h pre-incubation of <t>F9</t> cells with protein solvent buffer or various concentrations of recombinant SELENOV on cell viability. ( A ) Viability cytogram of F9 cells following treatment with 100 μL/mL (equivalent to 50 μg/mL SELENOV application) or 200 μL/mL (equivalent to 100 μg/mL SELENOV application) of solvent buffer. The 10 μg/mL SELENOV group was compared to the untreated control, as the corresponding buffer volume was negligible. ( B ) Viability cytogram of F9 cells after treatment with different concentrations of recombinant SELENOV. ( C ) Effects of solvent buffer or recombinant SELENOV on cell viability and activation of cell death pathways. Data are presented as mean ± SEM. Statistical significance was determined by one-way ANOVA followed by Tukey’s post hoc test. *** p < 0.001 versus the Control group; ### p < 0.001 versus the corresponding Buffer group.
    Mouse F9 Embryo Carcinoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/f9+cells/pm41168166-290-11-16?v=ATCC
    Average 95 stars, based on 1 article reviews
    mouse f9 embryo carcinoma cells - by Bioz Stars, 2026-07
    95/100 stars
    		  Buy from Supplier
    f9 embryonic carcinoma cells  (ATCC)
    95
    ATCC f9 embryonic carcinoma cells
    Effects of 24-h pre-incubation of <t>F9</t> cells with protein solvent buffer or various concentrations of recombinant SELENOV on cell viability. ( A ) Viability cytogram of F9 cells following treatment with 100 μL/mL (equivalent to 50 μg/mL SELENOV application) or 200 μL/mL (equivalent to 100 μg/mL SELENOV application) of solvent buffer. The 10 μg/mL SELENOV group was compared to the untreated control, as the corresponding buffer volume was negligible. ( B ) Viability cytogram of F9 cells after treatment with different concentrations of recombinant SELENOV. ( C ) Effects of solvent buffer or recombinant SELENOV on cell viability and activation of cell death pathways. Data are presented as mean ± SEM. Statistical significance was determined by one-way ANOVA followed by Tukey’s post hoc test. *** p < 0.001 versus the Control group; ### p < 0.001 versus the corresponding Buffer group.
    F9 Embryonic Carcinoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/f9+cells/pmc12575710__41467_2025_64609_MOESM9_ESM-65-0-7?v=ATCC
    Average 95 stars, based on 1 article reviews
    f9 embryonic carcinoma cells - by Bioz Stars, 2026-07
    95/100 stars
    		  Buy from Supplier
    f9 cells  (Procell Inc)
    86
    Procell Inc f9 cells
    Effects of 24-h pre-incubation of <t>F9</t> cells with protein solvent buffer or various concentrations of recombinant SELENOV on cell viability. ( A ) Viability cytogram of F9 cells following treatment with 100 μL/mL (equivalent to 50 μg/mL SELENOV application) or 200 μL/mL (equivalent to 100 μg/mL SELENOV application) of solvent buffer. The 10 μg/mL SELENOV group was compared to the untreated control, as the corresponding buffer volume was negligible. ( B ) Viability cytogram of F9 cells after treatment with different concentrations of recombinant SELENOV. ( C ) Effects of solvent buffer or recombinant SELENOV on cell viability and activation of cell death pathways. Data are presented as mean ± SEM. Statistical significance was determined by one-way ANOVA followed by Tukey’s post hoc test. *** p < 0.001 versus the Control group; ### p < 0.001 versus the corresponding Buffer group.
    F9 Cells, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/f9+cells/pm40059713-49-0-2?v=Procell+Inc
    Average 86 stars, based on 1 article reviews
    f9 cells - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    f9 teratocarcinoma cells  (ATCC)
    95
    ATCC f9 teratocarcinoma cells
    Effects of 24-h pre-incubation of <t>F9</t> cells with protein solvent buffer or various concentrations of recombinant SELENOV on cell viability. ( A ) Viability cytogram of F9 cells following treatment with 100 μL/mL (equivalent to 50 μg/mL SELENOV application) or 200 μL/mL (equivalent to 100 μg/mL SELENOV application) of solvent buffer. The 10 μg/mL SELENOV group was compared to the untreated control, as the corresponding buffer volume was negligible. ( B ) Viability cytogram of F9 cells after treatment with different concentrations of recombinant SELENOV. ( C ) Effects of solvent buffer or recombinant SELENOV on cell viability and activation of cell death pathways. Data are presented as mean ± SEM. Statistical significance was determined by one-way ANOVA followed by Tukey’s post hoc test. *** p < 0.001 versus the Control group; ### p < 0.001 versus the corresponding Buffer group.
    F9 Teratocarcinoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/f9+cells/pm40350206-156-10-15?v=ATCC
    Average 95 stars, based on 1 article reviews
    f9 teratocarcinoma cells - by Bioz Stars, 2026-07
    95/100 stars
    		  Buy from Supplier
    teratocarcinoma cell line f9  (ATCC)
    95
    ATCC teratocarcinoma cell line f9
    Effects of 24-h pre-incubation of <t>F9</t> cells with protein solvent buffer or various concentrations of recombinant SELENOV on cell viability. ( A ) Viability cytogram of F9 cells following treatment with 100 μL/mL (equivalent to 50 μg/mL SELENOV application) or 200 μL/mL (equivalent to 100 μg/mL SELENOV application) of solvent buffer. The 10 μg/mL SELENOV group was compared to the untreated control, as the corresponding buffer volume was negligible. ( B ) Viability cytogram of F9 cells after treatment with different concentrations of recombinant SELENOV. ( C ) Effects of solvent buffer or recombinant SELENOV on cell viability and activation of cell death pathways. Data are presented as mean ± SEM. Statistical significance was determined by one-way ANOVA followed by Tukey’s post hoc test. *** p < 0.001 versus the Control group; ### p < 0.001 versus the corresponding Buffer group.
    Teratocarcinoma Cell Line F9, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/f9+cells/pm39988346-55-42-46?v=ATCC
    Average 95 stars, based on 1 article reviews
    teratocarcinoma cell line f9 - by Bioz Stars, 2026-07
    95/100 stars
    		  Buy from Supplier
    cho-derived stable cell line expressing hhy6-f9  (Celltheon)
    90
    Celltheon cho-derived stable cell line expressing hhy6-f9
    Effects of 24-h pre-incubation of <t>F9</t> cells with protein solvent buffer or various concentrations of recombinant SELENOV on cell viability. ( A ) Viability cytogram of F9 cells following treatment with 100 μL/mL (equivalent to 50 μg/mL SELENOV application) or 200 μL/mL (equivalent to 100 μg/mL SELENOV application) of solvent buffer. The 10 μg/mL SELENOV group was compared to the untreated control, as the corresponding buffer volume was negligible. ( B ) Viability cytogram of F9 cells after treatment with different concentrations of recombinant SELENOV. ( C ) Effects of solvent buffer or recombinant SELENOV on cell viability and activation of cell death pathways. Data are presented as mean ± SEM. Statistical significance was determined by one-way ANOVA followed by Tukey’s post hoc test. *** p < 0.001 versus the Control group; ### p < 0.001 versus the corresponding Buffer group.
    Cho Derived Stable Cell Line Expressing Hhy6 F9, supplied by Celltheon, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/f9+cells/pm39907778-32-1-13?v=Celltheon
    Average 90 stars, based on 1 article reviews
    cho-derived stable cell line expressing hhy6-f9 - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Effects of 24-h pre-incubation of F9 cells with protein solvent buffer or various concentrations of recombinant SELENOV on cell viability. ( A ) Viability cytogram of F9 cells following treatment with 100 μL/mL (equivalent to 50 μg/mL SELENOV application) or 200 μL/mL (equivalent to 100 μg/mL SELENOV application) of solvent buffer. The 10 μg/mL SELENOV group was compared to the untreated control, as the corresponding buffer volume was negligible. ( B ) Viability cytogram of F9 cells after treatment with different concentrations of recombinant SELENOV. ( C ) Effects of solvent buffer or recombinant SELENOV on cell viability and activation of cell death pathways. Data are presented as mean ± SEM. Statistical significance was determined by one-way ANOVA followed by Tukey’s post hoc test. *** p < 0.001 versus the Control group; ### p < 0.001 versus the corresponding Buffer group.

    Journal: Biomolecules

    Article Title: Exogenous Selenoprotein V Induces Apoptosis in Murine Testicular Teratoma Cells via Mitochondrial Dysfunction and ROS Overproduction

    doi: 10.3390/biom15121733

    Figure Lengend Snippet: Effects of 24-h pre-incubation of F9 cells with protein solvent buffer or various concentrations of recombinant SELENOV on cell viability. ( A ) Viability cytogram of F9 cells following treatment with 100 μL/mL (equivalent to 50 μg/mL SELENOV application) or 200 μL/mL (equivalent to 100 μg/mL SELENOV application) of solvent buffer. The 10 μg/mL SELENOV group was compared to the untreated control, as the corresponding buffer volume was negligible. ( B ) Viability cytogram of F9 cells after treatment with different concentrations of recombinant SELENOV. ( C ) Effects of solvent buffer or recombinant SELENOV on cell viability and activation of cell death pathways. Data are presented as mean ± SEM. Statistical significance was determined by one-way ANOVA followed by Tukey’s post hoc test. *** p < 0.001 versus the Control group; ### p < 0.001 versus the corresponding Buffer group.

    Article Snippet: The study utilized several established cell lines: F9 cells (a murine embryonal carcinoma model derived from testicular teratoma of C57BL/6 mice) and mouse fibroblasts (L-929), all obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA).

    Techniques: Incubation, Solvent, Recombinant, Control, Activation Assay